Notch1 1 gene in esophageal squamous cell carcinoma

doi:10.3760/cma.j.issn.1673422X.2016.12.015

Abstract

ZHANG Lei, LI Duo-Jie. Notch1 1 gene in esophageal squamous cell carcinoma[J]. Journal of International Oncology, 2016, 43(12): 940-942.

［1］ Almhanna K, Strosberg JR. Multimodality approach for locally advanced esophageal cancer［J］. World J Gastroenterol, 2012, 18(40): 56795687. DOI: 10.3748/wjg.v18.i40.5679. ［2］ Song Y, Li L, Ou Y, et al. Identification of genomic alterations in oesophageal squamous cell cancer［J］. Nature, 2014, 509(7498): 9195. DOI: 10.1038/nature13176. ［3］ BednarzKnoll N, Efstathiou A, Gotzhein F, et al. Potential involvement of Jagged1 in metastatic progression of human creast carcinomas［J］. Clin Chem, 2016, 62(2): 378386. DOI: 10.1373/clinchem.2015.246686. ［4］ Wang R, Sun Q, Wang P, et al. Notch and Wnt/βcatenin signaling pathway play important roles in activating liver cancer stem cells［J］. Oncotarget, 2016, 7(5): 57545768. DOI: 10.18632/oncotarget.6805. ［5］ Brooks YS, Ostano P, Jo SH, et al. Multifactorial ERβ and NOTCH1 control of squamous differentiation and cancer［J］. J Clin Invest, 2014, 124(5): 22602276. DOI: 10.1172/JCI72718. ［6］ Lee SH, Do SI, Lee HJ, et al. Notch1 signaling contributes to stemness in head and neck squamous cell carcinoma［J］. Lab Invest, 2016, 96(5): 508516. DOI: 10.1038/labinvest.2015.163. ［7］刘兆国, 朱智杰, 周梁, 等. Notch信号通路与肿瘤研究［J］. 中国药理学通报, 2012, 28(8): 10451048. DOI: 10.3969/j.issn.10011978.2012.08.03. ［8］ Wang K, Johnson A, Ali SM, et al. Comprehensive genomic profiling of advanced esophageal squamous cell carcinomas and esophageal adenocarcinomas reveals similarities and differences［J］. Oncologist, 2015, 20(10): 11321139. DOI: 10.1634/theoncologist. ［9］鲁照明, 刘红涛, 高媛, 等. 人食管鳞癌及正常食管组织中Notchl基因的mRNA及蛋白的表达［J］. 华中师范大学学报(自然科学版), 2007, 41(2): 263267. ［10］ Yuan Y, Hu Y, Zhao Y, et al. Expressions of Notch signalingassociated proteins in esophageal squamous cell carcinoma［J］. Zhonghua Wei Chang Wai Ke Za Zhi, 2015, 18(9): 909913. ［11］ Lu Z, Liu H, Xue L, et al. An activated Notchl signaling pathway inhibits cell proliferation and induces apoptosis in human esophageal squamous cell carcinoma cell line EC9706［J］. Int J Oncol, 2008, 32(3): 643651. ［12］王丽萍, 江小强, 张海燕, 等. Notchl及PTEN在食管癌组织中的表达情况及临床意义［J］. 山西医药杂志, 2016, 45(1): 2325. DOI: 10.3969/j.issn.02539926.2016.01.007. ［13］苏春华, 苏毅华, 陈振光, 等. T3NOM0食管鳞癌中Notchl的表达及对肿瘤复发转移的预测［J］. 中华普通外科学文献: 电子版, 2012, 6(5): 405409. DOI: 10.3877/cma.j.issn.16740793.2012.05.007. ［14］ Song B, Cui H, Li Y, et al. Mutually exclusive mutations in NOTCH1 and PIK3CA associated with clinical prognosis and chemotherapy responses of esophageal squamous cell carcinoma in China［J］. Oncotarget, 2016, 7(3): 35993613. DOI: 10.18632/oncotarget.6120. ［15］ Sasaki Y, Tamura M, Koyama R, et al. Genomic characterization of esophageal squamous cell carcinoma: insights from nextgeneration sequencing［J］. World J Gastroenterol, 2016, 22(7): 22842293. DOI: 10.3748/wjg.v22.i7.2284. ［16］ Ogawa R, Ishiguro H, Kimura M, et al. NOTCH1 expression predicts patient prognosis in esophageal squamous cell cancer［J］. Eur Surg Res, 2013, 51(34): 101107. DOI: 10.1159/000355674. ［17］ Liu J, Fan H, Ma Y, et al. Notch1 is a 5fluorouracil resistant and poor survival marker in human esophagus squamous cell carcinomas［J］. PLoS One, 2013, 8(2): e56141. DOI: 10.1371/journal.pone.0056141.

[1]	Yang Mi, Bie Jun, Zhang Jiayong, Deng Jiaxiu, Tang Zuge, Lu Jun. Analysis of the efficacy and prognosis of neoadjuvant therapy for locally advanced resectable esophageal cancer [J]. Journal of International Oncology, 2024, 51(6): 332-337.
[2]	Liu Jing, Liu Qin, Huang Mei. Prognostic model construction of lung infection in patients with chemoradiotherapy for esophageal cancer based on SMOTE algorithm [J]. Journal of International Oncology, 2024, 51(5): 267-273.
[3]	Wan Fang, Yang Gang, Li Rui, Wan Qijing. Expression levels and clinical significance of serum miR-497 and miR-383 in patients with esophageal cancer [J]. Journal of International Oncology, 2024, 51(4): 204-209.
[4]	Gao Xinyu, Li Zhenjiang, Sun Hongfu, Han Dan, Zhao Qian, Liu Chengxin, Huang Wei. Clinical application of MR-guided radiotherapy based on MR-linac in esophageal cancer patients [J]. Journal of International Oncology, 2024, 51(1): 37-42.
[5]	Shandong Medical Association Multidisciplinary Joint Committee on Lung Cancer. Shandong Provincial Medical Association multidisciplinary standardized diagnosis and treatment guidelines for esophageal carcinoma （2023 Edition） [J]. Journal of International Oncology, 2023, 50(7): 385-397.
[6]	Zeng Liwu, Du Yuqiang, Zhang Peng, Tao Kaixiong. Progress in imaging evaluation of lateral lymph node metastasis in rectal cancer [J]. Journal of International Oncology, 2023, 50(4): 248-251.
[7]	Ji Shiyu, Zhang Mingxin, Xie Huahong, Bai Yuan, Wang Tong. Observation on the efficacy of different stents in the treatment of patients with advanced esophageal cancer [J]. Journal of International Oncology, 2023, 50(2): 76-81.
[8]	Gong Heyi, Yi Yan, Zhang Jian, Li Baosheng. Management strategies for locally advanced operable esophageal carcinoma achieving clinical complete response after neoadjuvant chemoradiotherapy [J]. Journal of International Oncology, 2023, 50(12): 745-750.
[9]	Wu Puyuan, Qi Liang, Wang Tao, Shi Minke, Sun Yuwei, Wang Lifeng, Liu Baorui, Yan Jing, Ren Wei. Efficacy of postoperative radiotherapy based on modified clinical target volume according to high-frequency recurrence regions in patients with esophageal squamous cell carcinoma [J]. Journal of International Oncology, 2022, 49(8): 464-472.
[10]	Xia Lingling, Chen Yongshun, Li Bin, Ning Tingting, Zhang Caiyutian. Comparison of safety and efficacy between chemoradiotherapy and chemotherapy after R0 resection in pN₊ esophageal squamous cell carcinoma patients [J]. Journal of International Oncology, 2022, 49(6): 334-339.
[11]	Ye Qian, Ling Zhi, Liu Shenxiang, Lu Guotao, Yin Xudong. Effects of sarcopenia on the clinical efficacy and prognosis of radical radiotherapy in elderly patients with esophageal cancer [J]. Journal of International Oncology, 2022, 49(4): 199-205.
[12]	Zhou Jianfeng, Wang Tiejun. Targeted therapy and immunotherapy of esophageal cancer [J]. Journal of International Oncology, 2022, 49(4): 237-242.
[13]	Liu Jia, Ge Xiaolin, Di Xiaoke, Shi Yujing, Zeng Yuting. Efficacy analysis of Xiyanping injection on prevention of radioactive esophagitis [J]. Journal of International Oncology, 2022, 49(3): 146-150.
[14]	Zhang Junpeng, Yu Yanyan, Li Baosheng. Mechanism of lncRNA and circRNA regulating the sensitivity of radiotherapy and chemotherapy in esophageal squamous cell carcinoma [J]. Journal of International Oncology, 2022, 49(3): 185-189.
[15]	Geng Hui, Hu Fengchao, Lu Hongchao, Guo Jungang, Qi Zengping. Effects of TPF regimen and IMRT on immune function and survival prognosis of patients with advanced esophageal cancer [J]. Journal of International Oncology, 2022, 49(2): 84-88.

Notch1 1 gene in esophageal squamous cell carcinoma

PDF

Knowledge

Abstract

Cite this article

share this article

References

Related Articles 15

Recommended Articles

Metrics

Comments